5. Hill EM, Newlin DB. Evolutionary approaches to addiction. Addiction. 2002 Apr;97(4):375–9.
6. Hyman SE. Addiction: a disease of learning and memory. FOCUS. 2007 Apr 1;5(2):220–8.
7. Nesse RM, Berridge KC. Psychoactive drug use in evolutionary perspective. Science. 1997;278(5335):63–6.
8. Dudley R. Evolutionary origins of human alcoholism in primate frugivory. Q Rev Biol. 2000;75(1):3–15.
9. Sullivan RJ, Hagen EH. Psychotropic substance-seeking: evolutionary pathology or adaptation? Addiction. 2002 Apr 1;97(4):389–400.
10. Chevallier J. The great medieval water myth. Les Leftovers [Internet]. 2013 [cited 2017 Dec 20]. Available from: https://leslefts.blogspot.com.au/2013/11/the-great-medieval-water-myth.html.
11. Dudley R. Ethanol, fruit ripening, and the historical origins of human alcoholism in primate frugivory. Integr Comp Biol. 2004 Aug;44(4):315–23.
12. Nesse RM. Evolution and addiction. Addiction. 2002 Apr;97(4):470–1.
13. Hayden B, Canuel N, Shanse J. What was brewing in the Natufian?: an archaeological assessment of brewing technology in the Epipaleolithic. J Archaeol Method Theory. 2013 Mar 1;20(1):102–50.
14. Sullivan RJ, Hagen EH. Psychotropic substance-seeking: evolutionary pathology or adaptation? Addiction. 2002 Apr 1;97(4):389–400.
15. Roulette CJ, Mann H, Kemp BM, Remiker M, Roulette JW, Hewlett BS, et al. Tobacco use vs. helminths in Congo basin hunter-gatherers: self-medication in humans? Evol Hum Behav. 2014 Sep 1;35(5):397–407.
16. Ruiz-Lancheros E, Viau C, Walter TN, Francis A, Geary TG. Activity of novel nicotinic anthelmintics in cut preparations of Caenorhabditis elegans. Int J Parasitol. 2011;41(3–4):455–61.
17. Gardner EL. What we have learned about addiction from animal models of drug self-administration. Am J Addict. 2000 Oct 1;9(4):285–313.
18. Sullivan RJ, Hagen EH. Psychotropic substance-seeking.
19. Hagen EH, Sullivan RJ, Schmidt R, Morris G, Kempter R, Hammerstein P. Ecology and neurobiology of toxin avoidance and the paradox of drug reward. Neuroscience. 2009;160(1):69–84.
20. Hagen EH, Roulette CJ, Sullivan RJ. Explaining human recreational use of “pesticides”: the neurotoxin regulation model of substance use vs. the hijack model and implications for age and sex differences in drug consumption. Front Psychiatry [Internet]. 2013 [cited 2017 Dec 20];4. Available from: http://journal.frontiersin.org/article/10.3389/fpsyt.2013.00142/abstract.
21. Turke PW, Betzig LL. Those who can do: wealth, status, and reproductive success on Ifaluk. Ethology and Sociobiology 1985;6(2):79–87. Available from: https://doi.org/10.1016/0162-3095(85)90001-9.
22. McLaughlin GT. Cocaine: the history and regulation of a dangerous drug. Cornell Rev. 1972;58(3):537–73.
23. Markel H. An anatomy of addiction: Sigmund Freud, William Halsted, and the miracle drug cocaine. New York: Vintage; 2011.
24. Davenport-Hines R. The pursuit of oblivion: a social history of drugs. London: Weidenfeld & Nicolson; 2012.
25. Brownstein MJ. A brief history of opiates, opioid peptides, and opioid receptors. Proc Natl Acad Sci. 1993;90(12):5391–3.
26. Brown RH. The opium trade and opium policies in India, China, Britain, and the United States: historical comparisons and theoretical interpretations. Asian J Soc Sci. 2002;30(3):623–56.
27. Braswell SR. American meth: a history of the methamphetamine epidemic in America. Lincoln (NE): iUniverse; 2006.
28. Pubchem. Carefentanil [Internet]. 2017 [cited 2017 Dec 20]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/62156.
29. McLaughlin K. Underground labs in China are devising potent new opiates faster than authorities can respond. Science [Internet]. 2017 Mar 29 [cited 2017 Dec 20]. Available from: http://www.sciencemag.org/news/2017/03/underground-labs-china-are-devising-potent-new-opiates-faster-authorities-can-respond.
30. Berridge KC, Robinson TE. The mind of an addicted brain: neural sensitization of wanting versus liking. Curr Dir Psychol Sci. 1995;4(3):71–6.
31. Kendler KS, Maes HH, Sundquist K, Ohlsson H, Sundquist J. Genetic and family and community environmental efects on drug abuse in adolescence: a Swedish national twin and sibling study. Am J Psychiatry. 2014 Feb 1;171(2):209–17.
32. Young SE, Rhee SH, Stallings MC, Corley RP, Hewitt JK. Genetic and environmental vulnerabilities underlying adolescent substance use and problem use: general or specific? Behav Genet. 2006;36(4):603–15.
33. Alexander BK, Hadaway PF. Opiate addiction: the case for an adaptive orientation. Psychol Bull. 1982;92(2):367–81.
34. Zucker RA. Genes, brain, behavior, and context: the developmental matrix of addictive behavior. In: Stoltenberg S, editor. Genes and the motivation to use substances [Internet]. New York: Springer; 2014 [cited 2017 Dec 20]. pp. 51–69. Available from: https://link.springer.com/chapter/10.1007/978-1-4939-0653-6_4.
35. Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016 Jan 28;374(4):363–71.
CHAPTER 14 | MINDS UNBALANCED ON FITNESS CLIFFS
1. Wiener N. Cybernetics; or, control and communication in the animal and the machine. Cambridge (MA): Technology Press; 1948. p. 151.
2. Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet. 2003 Nov 15;123 C(1): 48–58.
3. Sullivan RJ, Allen JS. Natural selection and schizophrenia. Behav Brain Sci. 2004 Dec;27(6):865–6.
4. Sandin S, Lichtenstein P, Kuja-Halkola R, Larsson H, Hultman CM, Reichenberg A. The familial risk of autism. JAMA. 2014 May 7;311(17):1770–7.
5. Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder.
6. Sandin S, et al. The familial risk of autism.
7. Lichtenstein P, Björk C, Hultman CM, Scolnick E, Sklar P, Sullivan PF. Recurrence risks for schizophrenia in a Swedish national cohort. Psychol Med. 2006 Oct;36(10):1417–25.
8. Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the “kindling” hypothesis. Am J Psychiatry. 2000 Aug 1;157(8):1243–51.
9. Ellison Z, van Os J, Murray R. Special feature: childhood personality characteristics of schizophrenia: manifestations of, or risk factors for, the disorder? J Personal Disord. 1998 Sep 1;12(3):247–61.
10. Johnson EC, Border R, Melroy-Greif WE, de Leeuw CA, Ehringer MA, Keller MC. No evidence that schizophrenia candidate genes are more associated with schizophrenia than noncandidate genes. Biol Psychiatry [Internet]. 2017 Jul 13 [cited 2017 Sep 15]. Available from: http://www.sciencedirect.com/science/article/pii/S0006322317317729.
11. Sanders AR, Duan J, Levinson DF, Shi J, He D, Hou C, et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry. 2008 Apr 1;165(4):497–506.
12. Anttila V, Bulik-Sullivan B, Finucane HK, Bras J, Duncan L, Escott-Price V, et al. Analysis of shared heritability in common disorders of the brain. 2016 Apr 16 [cited 2017 Jun 19]. Available from: http://biorxiv.org/lookup/doi/10.1101/048991.
13. Kendler KS. What psychiatric genetics has taught us about the nature of psychiatric illness and what is left to learn. Mol Psychiatry. 2013 Oct;18(10):1058–66.
14. Corvin A, Sullivan PF. What next in schizophrenia genetics for the Psychiatric Genomics Consortium? Schizophr Bull. 2016 May 1;42(3):538–41.
15. Forstner AJ, Hecker J, Hofmann A, Maaser A, Reinbold CS, Mühleisen TW, et al. Identification of shared risk loci and pathways for bipolar disorder and schizophrenia. PLOS ONE. 2017 Feb 6;12(2):e0171595.
16. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet. 2010 Jun;11(6):446–50.
&nbs
p; 17. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature. 2009 Oct 8;461(7265):747–53.
18. Nolte IM, van der Most PJ, Alizadeh BZ, de Bakker PI, Boezen HM, Bruinenberg M, et al. Missing heritability: is the gap closing? An analysis of 32 complex traits in the Lifelines Cohort Study. Eur J Hum Genet EJHG. 2017 Jun;25(7):877–85.
19. Gaugler T, Klei L, Sanders SJ, Bodea CA, Goldberg AP, Lee AB, et al. Most genetic risk for autism resides with common variation. Nat Genet. 2014 Aug;46(8):881–5.
20. Gratten J, Wray NR, Keller MC, Visscher PM. Large-scale genomics unveils the genetic architecture of psychiatric disorders. Nat Neurosci. 2014;17(6):782–90.
21. Kendler KS. What psychiatric genetics has taught us about the nature of psychiatric illness and what is left to learn. Mol Psychiatry. 2013 Oct;18(10):1058–66.
22. Woo HJ, Yu C, Kumar K, Reifman J. Large-scale interaction effects reveal missing heritability in schizophrenia, bipolar disorder and posttraumatic stress disorder. Transl Psychiatry. 2017 Apr 11;7(4):e1089.
23. Gaugler T et al. Most genetic risk for autism resides with common variation.
24. Cardno AG, Owen MJ. Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder. Schizophr Bull. 2014 May 1;40(3):504–15.
25. Malaspina D, Harlap S, Fennig S, Heiman D, Nahon D, Feldman D, et al. Advancing paternal age and the risk of schizophrenia. Arch Gen Psychiatry. 2001 Apr 1;58(4):361–7.
26. Reichenberg A, Gross R, Weiser M, Bresnahan M, Silverman J, Harlap S, et al. Advancing paternal age and autism. Arch Gen Psychiatry. 2006 Sep 1;63(9):1026–32.
27. Gratten J, Wray NR, Peyrot WJ, McGrath JJ, Visscher PM, Goddard ME. Risk of psychiatric illness from advanced paternal age is not predominantly from de novo mutations. Nat Genet. 2016 Jul;48(7):718–24.
28. Pedersen CB, McGrath J, Mortensen PB, Petersen L. The importance of father’s age to schizophrenia risk. Mol Psychiatry. 2014 May;19(5):530–1.
29. Bundy H, Stahl D, MacCabe JH. A systematic review and meta-analysis of the fertility of patients with schizophrenia and their unaffected relatives. Acta Psychiatr Scand. 2011;123(2):98–106.
30. Power RA, Kyaga S, Uher R, MacCabe JH, Långström N, Landen M, et al. Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings. JAMA Psychiatry. 2013 Jan 1;70(1):22–30.
31. Ibid.
32. Keller MC, Miller G. Resolving the paradox of common, harmful, heritable mental disorders: which evolutionary genetic models work best? Behav Brain Sci. 2006 Aug;29(4):385–404.
33. Crespi B, Badcock CR. Psychosis and autism as diametrical disorders of the social brain. Behav Brain Sci. 2008 Jun;31(3):241–61; discussion 261–320.
34. Crespi BJ. Revisiting Bleuler: relationship between autism and schizophrenia. Br J Psychiatry. 2010 Jun;196(6):495; author reply 495–6.
35. Wilkins JF, Haig D. What good is genomic imprinting: the function of parent-specific gene expression. Nat Rev Genet. 2003;4(5):359–68.
36. Haig D. Transfers and transitions: parent-offspring conflict, genomic imprinting, and the evolution of human life history. Proc Natl Acad Sci. 2010 Jan 26;107 (Suppl 1):1731–5.
37. Patten MM, Úbeda F, Haig D. Sexual and parental antagonism shape genomic architecture. Proc R Soc Lond B Biol Sci. 2013;280(1770):20131795.
38. Crespi BJ. The evolutionary etiologies of autism spectrum and psychotic affective spectrum disorders. In: Evolutionary thinking in medicine [Internet]. Cham (Switzerland): Springer; 2016 [cited 2018 Jan 2]. p. 299–327. Available from: https://link.springer.com/chapter/10.1007/978-3-319-29716-3_20.
39. Crespi BJ. Autism, psychosis, and genomic imprinting: recent discoveries and conundrums. Curr Opin Behav Sci. 2018;25:1–7.
40. Crespi B, Summers K, Dorus S. Adaptive evolution of genes underlying schizophrenia. Proc R Soc Lond B Biol Sci. 2007 Nov 22;274(1627):2801–10.
41. Dinsdale NL, Hurd PL, Wakabayashi A, Elliot M, Crespi BJ. How are autism and schizotypy related?: evidence from a non-clinical population. PLOS ONE. 2013;8(5):e63316.
42. Byars SG, Stearns SC, Boomsma JJ. Opposite risk patterns for autism and schizophrenia are associated with normal variation in birth size: phenotypic support for hypothesized diametric gene-dosage effects. Proc R Soc B. 2014 Nov 7;281(1794):20140604.
43. Lai M-C, Lombardo MV, Auyeung B, Chakrabarti B, Baron-Cohen S. Sex/gender differences and autism: setting the scene for future research. J Am Acad Child Adolesc Psychiatry. 2015 Jan 1;54(1):11–24.
44. Baron-Cohen S, Knickmeyer RC, Belmonte MK. Sex differences in the brain: implications for explaining autism. Science. 2005 Nov 4;310(5749):819–23.
45. van Dongen J, Boomsma DI. The evolutionary paradox and the missing heritability of schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2013 Mar 1;162(2):122–36.
46. Polimeni J, Reiss JP. Evolutionary perspectives on schizophrenia. Can J Psychiatry. 2003;48(1):34–9.
47. Stevens A. Prophets, cults and madness. London: Gerald Duckworth & Co.; 2000.
48. Nettle D, Clegg H. Schizotypy, creativity and mating success in humans. Proc R Soc Lond B Biol Sci. 2006;273(1586):611–5.
49. Greenwood TA. Positive traits in the bipolar spectrum: the space between madness and genius. Mol Neuropsychiatry. 2016;2(4):198–212.
50. Jamison KR. Touched with fire: manic-depressive illness and the artistic temperament. New York: Free Press; 1993.
51. Higier RG, Jimenez AM, Hultman CM, Borg J, Roman C, Kizling I, et al. Enhanced neurocognitive functioning and positive temperament in twins discordant for bipolar disorder. Am J Psychiatry. 2014;171(11):1191–8.
52. Polimanti R, Gelernter J. Widespread signatures of positive selection in common risk alleles associated to autism spectrum disorder. PLOS Genet. 2017 Feb 10;13(2):e1006618.
53. Zheutlin AB, Viehman RW, Fortgang R, Borg J, Smith DJ, Suvisaari J, et al. Cognitive endophenotypes inform genome-wide expression profiling in schizophrenia. Neuropsychology. 2016;30(1):40–52.
54. Woo HJ, Yu C, Kumar K, Reifman J. Large-scale interaction effects reveal missing heritability in schizophrenia, bipolar disorder and posttraumatic stress disorder. Transl Psychiatry. 2017 Apr 11;7(4):e1089.
55. Srinivasan S, Bettella F, Hassani S, Wang Y, Witoelar A, Schork AJ, et al. Probing the association between early evolutionary markers and schizophrenia. PLOS ONE. 2017 Jan 12;12(1):e0169227.
56. Chen H, Li C, Zhou Z, Liang H. Fast-evolving human-specific neural enhancers are associated with aging-related diseases. Cell Syst. 2018 May;6(5):604–11.
57. Corbett S, Courtiol A, Lummaa V, Moorad J, Stearns S. The transition to modernity and chronic disease: mismatch and natural selection.
58. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord. 2003 Jan 1;73(1):123–31.
59. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64(5):543–52.
60. Wilson DR. Evolutionary epidemiology and manic depression. Br J Med Psychol. 1998;71(4):375–95.
61. Abed RT, Abbas MJ. A reformulation of the social brain theory for schizophrenia: the case for out-group intolerance. Perspect Biol Med. 2011 Apr 28;54(2):132–51.
62. Stevens A, Price J. Evolutionary psychiatry: a new beginning. 2nd ed. Hove (UK): Psychology Press; 2000.
63. Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl. 1992 Jan;20:1–97.
64. Jongsma HE, Gayer-Anderson C, Lasalvia A, Quattrone D, Mulè A, Szöke A, et al. Treated incidence of psychotic disorders in the multinational EU-GEI Study. JAMA Psychiatry [Internet]. 2017 Dec 6 [cited 2018 Jan 2]. Available from: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2664479.
65. McGrath JJ. Variations in the incidence of schizophrenia: data versus dogma. Schizophr Bull. 2006 Jan 1;32(1):195–7.
66. Torrey EF, Bartko JJ, Yolken RH. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull. 2012 May 1;38(3):642–7.
67. Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M, et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry. 2004 Aug 1;61(8):774–80.
68. Kendell RE, Kemp IW. Maternal influenza in the etiology of schizophrenia. Arch Gen Psychiatry. 1989;46(10):878–82.
69. Kunugi H, Nanko S, Takei N, Saito K, Hayashi N, Kazamatsuri H. Schizophrenia following in utero exposure to the 1957 influenza epidemics in Japan. Am J Psychiatry. 1995;152(3):450–2.
70. Brüne M. Social cognition and behaviour in schizophrenia. Soc Brain Evol Pathol. 2003;277–313.
71. Crespi B, Summers K, Dorus S. Adaptive evolution of genes underlying schizophrenia. Proc R Soc Lond B Biol Sci. 2007 Nov 22;274(1627):2801–10.
72. Crow TJ. Is schizophrenia the price that Homo sapiens pays for language? Schizophr Res. 1997;28(2):127–41.
73. Brüne M. “Theory of mind” in schizophrenia: a review of the literature. Schizophr Bull. 2005;31(1):21–42.
74. Corvin A, Sullivan PF. What next in schizophrenia genetics for the Psychiatric Genomics Consortium? Schizophr Bull. 2016 May;42(3):538–41.
75. Crespi BJ. The Evolutionary etiologies of autism spectrum and psychotic affective spectrum disorders. In: Evolutionary thinking in medicine [Internet]. Cham (Switzerland): Springer; 2016 [cited 2018 Jan 2]. pp. 299–327. (Advances in the Evolutionary Analysis of Human Behaviour). Available from: https://link.springer.com/chapter/10.1007/978-3-319-29716-3_20
Good Reasons for Bad Feelings Page 39
